• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2502038 10%脂肪乳(OO)/5.5%氨基酸(15)/葡萄糖(20%)注射液 alanine;arginine;Calcium chloride;glycine;histidine;isoleucine;leucine;lysine;Magnesium chloride;Methionone;phenylalanine;Potassium chloride;proline;serine;Sodium acetate;Sodium glycerophosphate;threo Injection Chemical Drugs(4) Generic Drug 2025-06-10 Liaoning Haisco Pharmaceutical Co Ltd view
CXSL2500482 AK109注射液 pulocimab Injection Biological Products(1) New Drug Application 2025-06-12 Kangrong Oriental (Guangdong) Pharmaceutical Co Ltd view
CXSL2500480 AK117注射液 Injection Biological Products(1) New Drug Application 2025-06-12 Zhongshan Kangfang Biology Medicine Co Ltd view
CXSL2500481 AK117注射液 Injection Biological Products(1) New Drug Application 2025-06-12 Zhongshan Kangfang Biology Medicine Co Ltd view
CXSL2500484 AK131注射液 AK-131 Injection Biological Products(1) New Drug Application 2025-06-12 Zhongshan Kangfang Biology Medicine Co Ltd view
JTS2500042 ALXN1720注射液 gefurulimab Injection Biological Products Disposable Import Drug Application 2025-06-12 Patheon Italia SpA;Alexion Europe SAS;AstraZeneca Global R&D (China) Co Ltd view
JTS2500041 ALXN1720注射液 gefurulimab Injection Biological Products Disposable Import Drug Application 2025-06-12 Patheon Italia SpA;Alexion Europe SAS;AstraZeneca Global R&D (China) Co Ltd view
JXHL2500136 ARV-471(PF-07850327)片 Tablet Chemical Drugs(1) Import Drug Application 2025-06-12 Pfizer Inc;Pfizer Investment Co Ltd view
JXHL2500138 Baxdrostat片 baxdrostat Tablet Chemical Drugs(1) Import Drug Application 2025-06-12 AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXHL2500137 Baxdrostat片 baxdrostat Tablet Chemical Drugs(1) Import Drug Application 2025-06-12 AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXHB2500072 Bexicaserin口服溶液 bexicaserin Chemical Drugs(1) Supplementary Application 2025-06-12 Avema Pharma Solutions;Longboard Pharmaceuticals Inc;Patheon Inc view
JXHL2500132 BI 690517片 BI-690517 Tablet Chemical Drugs(1) Import Drug Application 2025-06-11 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXSB2500051 BION-1301注射液 zigakibart Injection Biological Products(1) Supplementary Application 2025-06-12 Patheon Italia SpA;Novartis Pharma Schweiz AG view
JXHL2500139 BMS-986504片 Chemical Drugs(1) Import Drug Application 2025-06-12 Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd view
CXSL2500474 CM536注射液 Biological Products(1) New Drug Application 2025-06-11 Keymed Biomedical Technology (Chengdu) Co Ltd view
CXSL2500477 CVL006 注射液 CVL-006 Injection Biological Products(1) New Drug Application 2025-06-12 Fukang (Shanghai) Health Technology Co Ltd view
CXHL2500560 D-2570片 D-2570 Tablet Chemical Drugs(1) New Drug Application 2025-06-12 InventisBio Co Ltd view
JXSL2500087 Dostarlimab注射液 dostarlimab Injection Biological Products(3.1) Import Drug Application 2025-06-11 GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline (Ireland) Ltd view
JXSB2500052 DS-1062a datopotamab deruxtecan Injection Biological Products(1) Supplementary Application 2025-06-12 Daiichi Sankyo Co Ltd;Baxter Oncology GmbH view
CXHB2500159 GenSci122片 GenSci122 Tablet Chemical Drugs(1) Supplementary Application 2025-06-07 Changchun GeneScience Pharmaceutical Co Ltd view